
Aarvik Therapeutics Presents New ADC Molecules at AACR 2026
Aarvik Therapeutics Unveils Novel ADCs at AACR 2026 Aarvik Therapeutics, a biotechnology company focused on advancing antibody-drug conjugate (ADC) technologies, has announced its participation in the AACR Annual Meeting 2026,…












